XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Income (Loss) (unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 3,708 $ 3,609 $ 10,928 $ 10,761
Cost of sales 2,591 2,564 7,425 7,083
Gross margin 1,117 1,045 3,503 3,678
Selling, general and administrative expenses 1,002 941 2,961 2,958
Research and development expenses 166 151 495 448
Goodwill impairments 0 2,785 0 2,785
Other operating expense (income), net 0 48 (14) 20
Operating income (loss) (51) (2,880) 61 (2,533)
Interest expense, net 128 104 369 278
Other (income) expense, net (7) 61 33 1
Loss from continuing operations before income taxes (172) (3,045) (341) (2,812)
Income tax benefit (223) (54) (199) (14)
Income (loss) from continuing operations 51 (2,991) (142) (2,798)
Income from discontinued operations, net of tax 2,460 57 2,559 192
Net income (loss) 2,511 (2,934) 2,417 (2,606)
Net income attributable to noncontrolling interests 3 3 6 8
Net income (loss) attributable to Baxter stockholders $ 2,508 $ (2,937) $ 2,411 $ (2,614)
Income (loss) from continuing operations per common share        
Income from continuing operations per common share, basic (in dollars per share) $ 0.09 $ (5.94) $ (0.29) $ (5.58)
Income from continuing operations per common share, diluted (in dollars per share) 0.09 (5.94) (0.29) (5.58)
Income from discontinued operations per common share        
Income from discontinued operations per common share, basic (in dollars per share) 4.85 0.11 5.06 0.38
Income from discontinued operations per common share, diluted (in dollars per share) 4.83 0.11 5.06 0.38
Net income (loss) per common share        
Basic (in dollars per share) 4.95 (5.83) 4.76 (5.20)
Diluted (in dollars per share) $ 4.93 $ (5.83) $ 4.76 $ (5.20)
Weighted-average number of shares outstanding        
Basic (in shares) 507 504 506 503
Diluted (in shares) 509 504 506 503